clinical trials

Cancer researchers in biotech and pharma highlight the clinical trials and developments they’re most excited about.

Among the thrill of new results presented at the AACR 2025 conference, the specter of funding cuts to cancer research hung over the meeting.

Landmark women’s health study loses funding, a promising antibody-drug conjugate for breast cancer, a schizophrenia drug setback, and more news from this week.

QurAlis researchers have developed QRL-101, a new drug candidate that targets overactive neurons to prevent cell death in ALS.  

Stem cell therapy for Parkinson’s disease, discontinuation of Pfizer’s GLP-1 drug, a pig liver clinical trial, and more biotech and pharma news from this week.

Biotech and pharma leaders reveal the neurological therapies in development that they’re most excited about.

Uniquity Bio seeks to investigate compounds that might otherwise sit on the shelf forever. Their lead compound appears poised to prove their model works.

A statistical model using two measures of brain activity could anticipate if people given an injection would be in severe pain for the next month.

In a Phase 2b trial, Khondrion’s sonlicromanol led to significant health benefits for patients with mitochondrial disease linked to a common mutation. 

A new method for tracking dietary intake used DNA in stool to detect nutritional content from a broad range of foods.